{
    "title": "Pfizer mulls cost cuts on volatile COVID products demand",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12360473/Pfizer-misses-revenue-estimates-COVID-product-sales-decline.html",
    "date": "2023-08-01",
    "keywords": [
        "demand",
        "quarter",
        "company",
        "revenue",
        "covid19",
        "vaccine",
        "pill",
        "forecast",
        "pfizer",
        "end",
        "profit",
        "share",
        "program",
        "fall",
        "drugmaker",
        "tuesday",
        "point",
        "product",
        "peak",
        "return",
        "growth",
        "level",
        "uncertainty",
        "rest",
        "business",
        "ceo",
        "albert",
        "bourla",
        "treatment",
        "paxlovid",
        "covid",
        "range",
        "topselling",
        "competition",
        "generic",
        "deal",
        "cancertherapy",
        "specialist",
        "seagen",
        "research",
        "development",
        "companys",
        "premarket",
        "trading",
        "reporting",
        "bhanvi",
        "satija",
        "bengaluru",
        "editing",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}